Latest News

The COVID-19 subvariant "Nimbus" is known for its ultra-contagious and painful sore throat, described as "razor blade throat."

Yale School of Medicine's Scott Roberts, MD, weighs in on the “nimbus variant,” the newest COVID strain circulating in states neighboring Connecticut.

As summer begins, a highly contagious new COVID-19 variant called NB.1.8.1, or "Nimbus," is spreading rapidly in the United States. YSPH Professor Dr. Albert Ko says it is unclear if the new variant will cause a major wave of infections, but it is likely not to be as bad as previous waves if it does.

We are delighted to share that 38 Yale School of Medicine (YSM) colleagues have been selected to receive inaugural Staff Appreciation & Recognition Champions (ARC) Awards, which celebrate teams who exemplify collaboration, initiative, inspiration, and community service.

With more ticks surviving warmer winters brought on by climate change, the risk of tick-borne illness is higher than in the past. Yale School of Public Health Senior Research Scientist Dr. Peter Krause, MD, comments.

Margaret Fikrig, MD, associate professor of medicine (infectious diseases), thoughtful clinician, educator, and role model, will retire on June 30, 2025.

The Yale Institute for Global Health hosted its Second Annual Global Health Symposium on April 11, 2025, at the Yale School of Public Health. Topics included the important role academic institutions play in advocating for global health amidst the current policy environment, and how multidisciplinary academic and research partnerships at Yale support global health.

Congratulations to the Yale Department of Internal Medicine faculty members who were recently promoted, appointed, or reappointed.

In a new study, published in Nature Medicine, a team of researchers at the Center for Phage Biology and Therapy at Yale discovered a novel approach that may revolutionize the fight against antimicrobial resistance.